A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis, New England Journal of Medicine, vol.330, issue.9, pp.585-591, 1994. ,
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials, Neurology, vol.92, issue.14, pp.e1610-e1623, 2019. ,
Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis, Neuropathology and Applied Neurobiology, vol.16, issue.5, pp.401-410, 1990. ,
Immune reactivity in a mouse model of familial ALS correlates with disease progression, Neurology, vol.57, issue.7, pp.1282-1289, 2001. ,
Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?, Journal of Neurology, Neurosurgery & Psychiatry, vol.90, p.jnnp-2018-319586, 2019. ,
Expanded autologous regulatory T-lymphocyte infusions in ALS, Neurology - Neuroimmunology Neuroinflammation, vol.5, issue.4, p.e465, 2018. ,
Inflammation and neurovascular changes in amyotrophic lateral sclerosis, Molecular and Cellular Neuroscience, vol.53, pp.34-41, 2013. ,
Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials, Frontiers in Neurology, vol.8, p.486, 2017. ,
Regulatory T cells exert checks and balances on self tolerance and autoimmunity, Nature Immunology, vol.11, issue.1, pp.7-13, 2009. ,
Alterations of T cell subsets in ALS: a systemic immune activation?, Acta Neurologica Scandinavica, vol.125, issue.4, pp.260-264, 2011. ,
Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process, Journal of Neuroimmunology, vol.210, issue.1-2, pp.73-79, 2009. ,
Regulatory T?lymphocytes mediate amyotrophic lateral sclerosis progression and survival, EMBO Molecular Medicine, vol.5, issue.1, pp.64-79, 2012. ,
Tolerance, not immunity, crucially depends on IL-2, Nature Reviews Immunology, vol.4, issue.9, pp.665-674, 2004. ,
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo, Blood, vol.108, issue.5, pp.1571-1579, 2006. ,
Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction, Immunity, vol.28, issue.5, pp.687-697, 2008. ,
Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases, The Journal of Immunology, vol.203, issue.11, pp.2749-2755, 2019. ,
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial, The Lancet Diabetes & Endocrinology, vol.1, issue.4, pp.295-305, 2013. ,
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol.1, issue.5, pp.293-299, 2000. ,
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases, PLoS ONE, vol.8, issue.9, p.e75091, 2013. ,
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study, EBioMedicine, vol.3, pp.135-140, 2016. ,
The pairwise multiple comparison multiplicity problem: An alternative approach to familywise and comparison wise Type I error control., Psychological Methods, vol.4, issue.1, pp.58-69, 1999. ,
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis, Current Opinion in Neurology, vol.31, issue.5, pp.635-639, 2018. ,
CCL2-CCR2 Signaling in Disease Pathogenesis, Endocrine, Metabolic & Immune Disorders-Drug Targets, vol.15, issue.2, pp.105-118, 2015. ,
Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients, Neurological Research, vol.29, issue.8, pp.772-776, 2007. ,
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer?s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets, International Journal of Molecular Sciences, vol.19, issue.3, p.831, 2018. ,
Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS, Experimental Neurology, vol.237, issue.1, pp.147-152, 2012. ,
The chemokine system in diverse forms of macrophage activation and polarization, Trends in Immunology, vol.25, issue.12, pp.677-686, 2004. ,
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS, Journal of Clinical Investigation, vol.122, issue.9, pp.3063-3087, 2012. ,
Attributes of alternatively activated (M2) macrophages, Life Sciences, vol.224, pp.222-231, 2019. ,
Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, vol.18, issue.4, pp.208-215, 2018. ,
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages, Proceedings of the National Academy of Sciences, vol.104, issue.49, pp.19446-19451, 2007. ,
Expression of functional IL 2 receptors by lipopolysaccharide and interferongamma stimulated human monocytes, J Immunol Baltim Md, vol.138, pp.2917-2939, 19501987. ,
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod, Multiple Sclerosis Journal, vol.24, issue.8, pp.1046-1054, 2017. ,
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial, Acta Neurologica Scandinavica, vol.139, issue.5, pp.462-468, 2019. ,
Global rank tests for multiple, possibly censored, outcomes, Biometrics, vol.72, issue.3, pp.926-935, 2016. ,
Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis, JAMA Neurology, vol.75, issue.6, p.681, 2018. ,